In a study in France this week, combining 2 drugs was found to be effective for victims of the coronavirus disease, Cod-19, and similar results have now emerged in Australia.
Scientists at the University of Queensland have decided to launch a clinical trial of 2 drugs currently available.
Professor David Patterson, director of the University’s Center for Clinical Research, said that these drugs were very effective in test tube experiments, and we are now beginning to test them on patients, one of the drugs used for HIV. While the other is an anti-malaria drug.
He also said that before the trial on patients, these drugs were used by some of Australia’s first patients affected by Cod 19, who were fully recovered, and now their efficacy in this regard will be confirmed. Will
Researchers are now ready to test it on a larger scale, with 60 hospitals across Australia to determine their best use, he said.
According to him, the effects of using these drugs separately during the trial will be evaluated and the efficacy of the combination of the two will be tested, and work will begin soon.
“It will give us the experience of healing this way, because at this point we expect the outbreak to last for several months, if we get the best possible information now, we will have immediate treatment for patients in the near future,” he said. Will help.
These medicines will be administered to patients in the form of pills and according to Australian scientists our aim is to treat patients as quickly as possible and we want every Australian citizen to receive better treatment.
It is important to note that the drug used against malaria during this experiment is chloroquine (also known as hydroxychloroquine) and HIV-produced cholera (a combination of two antiviral drugs lupinavir and retonavir). Will be made part of this trial.
Earlier, a study in France reported that the combination of hydroxychloroquine and the antibiotic drug azithromycin used to treat malaria is also effective in treating Cod-19 and helps reduce the duration of the virus’s presence in patients.
The study, published in the journal International Journal of Anti-Microbial Agents, included 30 patients with code 19, and some were given only anti-malarial drugs, some with antibiotics while one was given. Both of these drugs were not used to the group.
There were 6 patients in the study who did not show any symptoms of the disease, 22 patients who had headache, sore throat and sneezing while others had cough like symptoms of lower respiratory tract. ۔
Research has found that anti-malarial drugs are also effective as a cure, but they are more effective when used together.
The research was conducted on a limited scale, but the results are encouraging because reports have emerged in China of using this treatment option.
The effects of a drug called favipiravir have been encouraging during clinical trials in Wuhan and Shenzhen, said Zheng Shin Min, a former Chinese Ministry of Science and Technology official.
The drug was used in 340 patients and the official said ‘it has proven to be very effective in treating it with being very safe’.
According to the report, in those patients who used the drug in Shenzhen, the virus ended 4 days after the test came out positive, while the use of other drugs for the symptoms of the disease without the drug required an average of 11 days to recover. ۔
In addition, the use of this new drug from X-ray confirmed the improvement in the lung condition of 91% of patients, while in other medicines the rate is close to 62%.
The drug was manufactured by Fuji Chemical in Toyama Chemicals in 2014, but declined to release a statement on its Chinese claim.
It is important to note that no effective treatment of Cod 19 has been available so far, but efforts are being made by scientists to find something that can help reduce the duration or severity of the disease.
Vaccine preparation is also underway, but effective vaccine preparation will require at least one to one-half year period.
In Pakistan, the number of Corona virus cases has increased steadily over the course of a week.
If you look at the number of victims across the country, so far it has been 666, including 357 in Sindh, 137 in Punjab, 104 in Balochistan, 27 in Khyber Pakhtunkhwa, 10 in Islamabad, 30 in Gilgit-Baltistan and one in Azad Kashmir. A case is involved.
So far 3 patients have died and 5 have recovered.
Worldwide, 11,576 deaths have been caused by the virus. So far, more than 2 lakh 78,000 people have been affected by the outbreak.